BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9029020)

  • 1. Disappearance of prognostic significance of histopathological grading of nodular sclerosing Hodgkin's disease for unselected patients, 1972-92.
    van Spronsen DJ; Vrints LW; Hofstra G; Crommelin MA; Coebergh JW; Breed WP
    Br J Haematol; 1997 Feb; 96(2):322-7. PubMed ID: 9029020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grades of nodular sclerosis (NSI-NSII) in Hodgkin's disease. Are they of independent prognostic value?
    Wijlhuizen TJ; Vrints LW; Jairam R; Breed WP; Wijnen JT; Bosch LJ; Crommelin MA; van Dam FE; de Koning J; Verhagen-Teulings M
    Cancer; 1989 Mar; 63(6):1150-3. PubMed ID: 2917317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of follicular dendritic cells in nodular sclerosing Hodgkin's disease.
    Baur AS; Meugé-Moraw C; Michel G; Delacrétaz F
    Histopathology; 1998 Jun; 32(6):512-20. PubMed ID: 9675590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic grade does not predict prognosis in optimally treated, advanced-stage nodular sclerosing Hodgkin's disease.
    Masih AS; Weisenburger DD; Vose JM; Bast MA; Armitage JO
    Cancer; 1992 Jan; 69(1):228-32. PubMed ID: 1727667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin disease, nodular sclerosis type. Implications of histologic subclassification.
    Ferry JA; Linggood RM; Convery KM; Efird JT; Eliseo R; Harris NL
    Cancer; 1993 Jan; 71(2):457-63. PubMed ID: 8422639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic grading of nodular sclerosis Hodgkin's disease. Lack of prognostic significance in 254 surgically staged patients.
    Hess JL; Bodis S; Pinkus G; Silver B; Mauch P
    Cancer; 1994 Jul; 74(2):708-14. PubMed ID: 8033052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin's disease in childhood: the British National Lymphoma Investigation experience (BNLI Report No 27).
    Makepeace AR; Maclennan KA; Hudson GV; Jelliffe AM
    Clin Radiol; 1987 Jan; 38(1):7-11. PubMed ID: 3816070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percentage of proliferating cell nuclear antigen (PCNA)-positive Reed-Sternberg cells in nodular sclerosis Hodgkin's disease.
    Kordek R; Biernat W; Niewiadomska H; Kupnicka D; Woźniak L; Domagała W; Osborn M
    Patol Pol; 1993; 44(3):129-31. PubMed ID: 7902558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclassification of Hodgkin's disease, nodular sclerosis type. Prognostic value?
    Norum J; Wist E; Nordøy T; Stalsberg H
    Anticancer Res; 1995; 15(4):1569-72. PubMed ID: 7654047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors.
    von Wasielewski R; Seth S; Franklin J; Fischer R; Hübner K; Hansmann ML; Diehl V; Georgii A
    Blood; 2000 Feb; 95(4):1207-13. PubMed ID: 10666192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials.
    von Tresckow B; Kreissl S; Goergen H; Bröckelmann PJ; Pabst T; Fridrik M; Rummel M; Jung W; Thiemer J; Sasse S; Bürkle C; Baues C; Diehl V; Engert A; Borchmann P;
    Lancet Haematol; 2018 Oct; 5(10):e462-e473. PubMed ID: 30290903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival of Hodgkin's patients in south-east Netherlands since 1972.
    van Spronsen DJ; Dijkema IM; Vrints LW; Hofstra G; Crommelin MA; Erdkamp FL; Coebergh JW; Breed WP
    Eur J Cancer; 1997 Mar; 33(3):436-41. PubMed ID: 9155529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin's disease: an analysis of 271 non-laparotomised cases (BNLI report no. 22).
    Bennett MH; MacLennan KA; Easterling MJ; Vaughan Hudson B; Jelliffe AM; Vaughan Hudson G
    Clin Radiol; 1983 Sep; 34(5):497-501. PubMed ID: 6617080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin's disease. The Danish National Hodgkin Study Group.
    Specht L; Lauritzen AF; Nordentoft AM; Andersen PK; Christensen BE; Hippe E; Hou-Jensen K; Nissen NI
    Cancer; 1990 Jun; 65(11):2594-601. PubMed ID: 2337876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients.
    MacLennan KA; Bennett MH; Tu A; Hudson BV; Easterling MJ; Hudson GV; Jelliffe AM
    Cancer; 1989 Oct; 64(8):1686-93. PubMed ID: 2790683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
    Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
    Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index.
    Haybittle JL; Hayhoe FG; Easterling MJ; Jelliffe AM; Bennett MH; Vaughan Hudson G; Vaughan Hudson B; MacLennan KA
    Lancet; 1985 Apr; 1(8435):967-72. PubMed ID: 2859421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.